39 related articles for article (PubMed ID: 22796190)
1. T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct.
Schlereth B; Quadt C; Dreier T; Kufer P; Lorenczewski G; Prang N; Brandl C; Lippold S; Cobb K; Brasky K; Leo E; Bargou R; Murthy K; Baeuerle PA
Cancer Immunol Immunother; 2006 May; 55(5):503-14. PubMed ID: 16032400
[TBL] [Abstract][Full Text] [Related]
2. Nanovesicles released by OKT3 hybridoma express fully active antibodies.
Logozzi M; Di Raimo R; Properzi F; Barca S; Angelini DF; Mizzoni D; Falchi M; Battistini L; Fais S
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):175-182. PubMed ID: 33404266
[TBL] [Abstract][Full Text] [Related]
3. Myeloid and dendritic cells enhance therapeutics-induced cytokine release syndrome features in humanized BRGSF-HIS preclinical model.
Martin GH; Gonon A; Martin-Jeantet P; Renart-Depontieu F; Biesova Z; Cifuentes A; Mukherjee A; Thisted T; Doerner A; Campbell DO; Bourré L; van der Horst EH; Rezza A; Thiam K
Front Immunol; 2024; 15():1357716. PubMed ID: 38384461
[TBL] [Abstract][Full Text] [Related]
4. Cytokine release assays for the prediction of therapeutic mAb safety in first-in man trials--Whole blood cytokine release assays are poorly predictive for TGN1412 cytokine storm.
Vessillier S; Eastwood D; Fox B; Sathish J; Sethu S; Dougall T; Thorpe SJ; Thorpe R; Stebbings R
J Immunol Methods; 2015 Sep; 424():43-52. PubMed ID: 25960173
[TBL] [Abstract][Full Text] [Related]
5. Self-assembled antibody multimers through peptide nucleic acid conjugation.
Kazane SA; Axup JY; Kim CH; Ciobanu M; Wold ED; Barluenga S; Hutchins BA; Schultz PG; Winssinger N; Smider VV
J Am Chem Soc; 2013 Jan; 135(1):340-6. PubMed ID: 23210862
[TBL] [Abstract][Full Text] [Related]
6. Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety.
MacLeod E; Rajagopal D; Vessillier S
J Vis Exp; 2023 Sep; (199):. PubMed ID: 37782084
[TBL] [Abstract][Full Text] [Related]
7. Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity?
van der Stegen SJ; Davies DM; Wilkie S; Foster J; Sosabowski JK; Burnet J; Whilding LM; Petrovic RM; Ghaem-Maghami S; Mather S; Jeannon JP; Parente-Pereira AC; Maher J
J Immunol; 2013 Nov; 191(9):4589-98. PubMed ID: 24062490
[TBL] [Abstract][Full Text] [Related]
8. Preclinical screening for acute toxicity of therapeutic monoclonal antibodies in a hu-SCID model.
Brady JL; Harrison LC; Goodman DJ; Cowan PJ; Hawthorne WJ; O'Connell PJ; Sutherland RM; Lew AM
Clin Transl Immunology; 2014 Dec; 3(12):e29. PubMed ID: 25587392
[TBL] [Abstract][Full Text] [Related]
9. Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes.
Jung S; Ben Nasr M; Bahmani B; Usuelli V; Zhao J; Sabiu G; Seelam AJ; Naini SM; Balasubramanian HB; Park Y; Li X; Khalefa SA; Kasinath V; Williams MD; Rachid O; Haik Y; Tsokos GC; Wasserfall CH; Atkinson MA; Bromberg JS; Tao W; Fiorina P; Abdi R
Adv Mater; 2023 Oct; 35(40):e2300812. PubMed ID: 37357903
[TBL] [Abstract][Full Text] [Related]
10. Cytokine release syndrome and cancer immunotherapies - historical challenges and promising futures.
Shah D; Soper B; Shopland L
Front Immunol; 2023; 14():1190379. PubMed ID: 37304291
[TBL] [Abstract][Full Text] [Related]
11. Humanized Mouse as a Tool to Predict Immunotoxicity of Human Biologics.
Yong KSM; Her Z; Tan SY; Tan WWS; Liu M; Lai F; Heng SM; Fan Y; Chang KTE; Wang CI; Chan JKY; Chen J; Chen Q
Front Immunol; 2020; 11():553362. PubMed ID: 33193321
[TBL] [Abstract][Full Text] [Related]
12. A rapid, sensitive, and reproducible in vivo PBMC humanized murine model for determining therapeutic-related cytokine release syndrome.
Ye C; Yang H; Cheng M; Shultz LD; Greiner DL; Brehm MA; Keck JG
FASEB J; 2020 Sep; 34(9):12963-12975. PubMed ID: 32772418
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profile of human T cells following a single stimulation of peripheral blood mononuclear cells with anti-CD3 antibodies.
Sousa IG; Simi KCR; do Almo MM; Bezerra MAG; Doose G; Raiol T; Stadler PF; Hoffmann S; Maranhão AQ; Brigido MM
BMC Genomics; 2019 Jul; 20(1):593. PubMed ID: 31324145
[TBL] [Abstract][Full Text] [Related]
14. Humanized mouse models of immunological diseases and precision medicine.
Shultz LD; Keck J; Burzenski L; Jangalwe S; Vaidya S; Greiner DL; Brehm MA
Mamm Genome; 2019 Jun; 30(5-6):123-142. PubMed ID: 30847553
[TBL] [Abstract][Full Text] [Related]
15. TGN1412 Induces Lymphopenia and Human Cytokine Release in a Humanized Mouse Model.
Weißmüller S; Kronhart S; Kreuz D; Schnierle B; Kalinke U; Kirberg J; Hanschmann KM; Waibler Z
PLoS One; 2016; 11(3):e0149093. PubMed ID: 26959227
[TBL] [Abstract][Full Text] [Related]
16. Scrutinizing calcium flux oscillations in T lymphocytes to deduce the strength of stimulus.
Christo SN; Diener KR; Nordon RE; Brown MP; Griesser HJ; Vasilev K; Christo FC; Hayball JD
Sci Rep; 2015 Jan; 5():7760. PubMed ID: 25585590
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a surrogate murine antibody to model anti-human CD3 therapies.
Dépis F; Hatterer E; Ballet R; Daubeuf B; Cons L; Glatt S; Reith W; Kosco-Vilbois M; Dean Y
MAbs; 2013; 5(4):555-64. PubMed ID: 23751612
[TBL] [Abstract][Full Text] [Related]
18. A humanised mouse model of cytokine release: comparison of CD3-specific antibody fragments.
Malcolm SL; Smith EL; Bourne T; Shaw S
J Immunol Methods; 2012 Oct; 384(1-2):33-42. PubMed ID: 22796190
[TBL] [Abstract][Full Text] [Related]
19. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
